The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8+ T lymphocytes in IFN-γ ELISPOT assays
- 1 January 2002
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 259 (1-2) , 95-110
- https://doi.org/10.1016/s0022-1759(01)00499-9
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- CD28/B7 SYSTEM OF T CELL COSTIMULATIONAnnual Review of Immunology, 1996
- Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.Journal of Clinical Investigation, 1995
- T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell ProfilesCritical Reviews in Immunology, 1995
- HLA class I alleles of LCL 721 and 174XCEM.T2 (T2)Tissue Antigens, 1994
- In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild‐type p53European Journal of Immunology, 1993
- Identification of peptide sequences that potentially trigger HLA‐A2.1‐restricted cytotoxic T lymphocytesEuropean Journal of Immunology, 1993
- The Biochemistry and Cell Biology of Antigen Processing and PresentationAnnual Review of Immunology, 1993
- HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptidesNature, 1992
- HLA-A2.1-Associated Peptides from a Mutant Cell Line: A Second Pathway of Antigen PresentationScience, 1992
- A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17Human Immunology, 1980